Investigation of the anti-fibrotic action of the NCE T03 in comparison to Pirfenidone in A549 cells. - Vienna 2024

Molecular pathways in asthma and chronic obstructive pulmonary disease

Chair(s): Francisco Javier Salgado Castro, Andrew Higham

Session type: Poster session

Investigation of the anti-fibrotic action of the NCE T03 in comparison to Pirfenidone in A549 cells.

Maria Brachs

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Navitoclax inhibits senescence markers in precision cut lung slices from COPD patients

Peter Fenwick

Poster

Abstract

MiR-15b regulation promoted by Nintedanib in CTD associated progressive pulmonary fibrosis

Eleonora Bozza

Poster

Abstract

Late Breaking Abstract - A splice-switching oligonucleotide (SSO) targeting the Receptor for Advanced Glycation End-products (RAGE) attenuates lung injury in smoke and AATD associated lung disease

Gary P. Anderson

Poster

Abstract

Deciphering the role of thromboxane A2 in mast cell-induced bronchoconstriction within human small airways

Jesper S?fholm

Poster

Abstract

GLCCI1 rs37973 and inhaled corticosteroids: findings from a European cohort of COPD patients

Charikleia Ntenti

Poster

Abstract

NO production depth in the conducting airways in T2-high asthma

Haopeng Xu

Poster

Abstract

Investigation of the anti-fibrotic action of the NCE T03 in comparison to Pirfenidone in A549 cells.

Maria Brachs

Poster

Abstract

Formulation of Solid Lipid Nanoparticles Loaded with Nociceptin/Orphanin FQ (N/OFQ) and Characterization in a Murine Model of Airway Hyperresponsiveness

Giuseppe Spaziano

Abstract

Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice

Yasemin Karaman

Poster

Abstract

GLUT1 promotes NLRP3 inflammasome activation of airway epithelium in lipopolysaccharide-induced acute lung injury

Jiehong Li

Abstract

Small airway function in patients with alpha1-antitrypsin deficiency. Correlation with quality of life and exercise capacity.

Dimitrios Toumpanakis

Poster

Abstract

Small Airways Disease (SAD) in Severe Asthma (SA) negatively affects the response to biologic therapy

Martina Maria Marinato

Poster

Abstract

Determinants of oxidative stress and antioxidant status in COPD

Maja Badovinac

Poster

Abstract

Increased epithelial thickness and luminal narrowing in the small airways of smokers with Preserved Ratio Impaired Spirometry (PRISm)

Hannah Trodden Mittnacht

Poster

Abstract

ARTEMISIA: A JAK1 inhibitor mechanistic study to advance molecular understanding and precision medicine in respiratory diseases

Zala Jevnikar Rojnik

Poster

Abstract

Metabolic signatures of non-typeable Haemophilus influenzae from COPD sputum

James Baker

Poster

Abstract

Yihuo Huatan Formula alleviate stable COPD symptoms by increasing the relative abundance of Faecalibacterium Prausnitzii

Cong Zhou

Poster

Abstract

Association of Airway Inflammation and Smoking Status with IL-33 expression in Sputum of Patients with Asthma or COPD

Mustafa Abdo

Poster

Abstract

Late Breaking Abstract - ?2-Adrenoceptor Dysfunction in Severe Asthma

Jameel Hakeem

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}